Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 18, 2019

SELL
$48.76 - $63.23 $17,066 - $22,130
-350 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$55.19 - $62.25 $165 - $186
3 Added 0.86%
350 $22,000
Q2 2018

Jul 27, 2018

BUY
$50.53 - $62.98 $17,533 - $21,854
347 New
347 $19,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wp Advisors, LLC Portfolio

Follow Wp Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wp Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wp Advisors, LLC with notifications on news.